SeaCrest Wealth Management’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-970
Closed -$16K – 587
2019
Q4
$16K Sell
970
-1,087
-53% -$15.6K ﹤0.01% 554
2019
Q3
$30K Sell
2,057
-754
-27% -$12.2K 0.01% 540
2019
Q2
$51K Sell
2,811
-1,544
-35% -$35K 0.01% 508
2019
Q1
$155K Sell
4,355
-1,607
-27% -$63.5K 0.03% 547
2018
Q4
$240K Buy
5,962
+1,815
+44% +$111K 0.05% 380
2018
Q3
$361K Buy
4,147
+1,055
+34% +$105K 0.06% 344
2018
Q2
$255K Buy
3,092
+1,638
+113% +$100K 0.05% 415
2018
Q1
$52K Sell
1,454
-1,491
-51% -$57.8K 0.01% 942
2017
Q4
$108K Buy
+2,945
New +$133K 0.02% 690

Other funds holding VSTM

SeaCrest Wealth Management's VSTM Position: Q1 2020 in Review

SeaCrest Wealth Management sold out of Verastem (VSTM) in Q1 2020, closing a stake of 970 shares — an estimated $16K sold.

SeaCrest Wealth Management first reported a position in VSTM in Q4 2017 and held it in 9 quarters. The position peaked at $361K in Q3 2018. 103 funds tracked by Wall St. Rank hold VSTM as of Q1 2020.

  • SeaCrest Wealth Management reported no remaining Verastem position as of Q1 2020 after selling out during the quarter.
  • SeaCrest Wealth Management sold 970 Verastem shares in Q1 2020, an estimated $16K.
  • SeaCrest Wealth Management first reported a position in Verastem in Q4 2017 and held it in 9 quarters.
  • SeaCrest Wealth Management's Verastem position peaked at $361K in Q3 2018.
  • 103 funds tracked by Wall St. Rank held Verastem as of Q1 2020.

Based on SeaCrest Wealth Management's 13F filing for Q1 2020, filed 13 May 2020.